SCHEMBL3119367

SCHEMBL3119367

COc1cc(CC(=N)NO)ccc1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
TSHR P16473 2/20 0.59
GAA P10253 1/20 0.59
NFKB1 P19838 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
ALOX5 P09917 2/20 0.55
CYP3A4 P08684 2/20 0.55
AR P10275 1/20 0.55
PTGS1 P23219 1/20 0.55
TRPM8 Q7Z2W7 1/20 0.55
TAAR1 Q96RJ0 2/20 0.54
MAPK1 P28482 1/20 0.54
FOS P01100 1/20 0.53
TTR P02766 1/20 0.53
JUN P05412 1/20 0.53
NR3C1 P04150 1/20 0.53
HSD17B1 P14061 1/20 0.53
HSD17B2 P37059 1/20 0.53
LMNA P02545 1/20 0.53
GLA P06280 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL836958 0.84 ALDH1A1 (0.47) ALDH1A1TSHRGAANFKB1TDP1
SCHEMBL1520671 0.80 TSHR (0.63) ALDH1A1TSHRGAANFKB1TDP1
SCHEMBL29844344 0.79 HSD17B10 (0.48) ALDH1A1GAATTRLMNA
SCHEMBL1751797 0.77 GAA (0.73) ALDH1A1TSHRGAANFKB1TDP1
SCHEMBL30128009 0.77 GAA (0.73) ALDH1A1TSHRGAANFKB1TDP1
SCHEMBL1031036 0.77 ALDH1A1 (0.73) ALDH1A1TSHRGAANFKB1TDP1
SCHEMBL7114863 0.76 TSHR (0.77) ALDH1A1TSHRGAANFKB1TDP1
SCHEMBL7739503 0.76 TAAR1 (0.61) ALDH1A1TSHRGAANFKB1TDP1
SCHEMBL2004305 0.75 ALDH1A1 (0.66) ALDH1A1TSHRGAANFKB1TDP1
SCHEMBL68178 0.75 CALM1 (0.79) ALDH1A1TSHRGAANFKB1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS XDH, GPR84, GPR88 ALDH1A1 600/4885TSHR 430/4885GAA 940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.